Abrogation of AuroraA-TPX2 by novel natural inhibitors: molecular dynamics-based mechanistic analysis

References

• Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442
   PubMed Web of Science ®Google Scholar
• Ashley L, Jones H, Thomas J, et al. Integrating patient reported outcomes with clinical cancer registry data: a feasibility study of the electronic patient-reported outcomes from cancer survivors (ePOCS) system. J Med Internet Res 2013;15:e230
   PubMed Web of Science ®Google Scholar
• Urruticoechea A, Alemany R, Balart J, et al. Recent advances in cancer therapy: an overview. Curr Pharm Des 2010;16:3–10
   PubMed Web of Science ®Google Scholar
• Tyagi C, Grover S, Dhanjal JK, et al. Mechanistic insights into mode of action of novel natural cathepsin L inhibitors. BMC Genom 2013;14:S10
   PubMed Web of Science ®Google Scholar
• Dhanjal JK, Grover S, Paruthi P, et al. Mechanistic insights into mode of action of a potent natural antagonist of orexin receptor-1 by means of high throughput screening and molecular dynamics simulations. Comb Chem High Throughput Screen 2014;17:124–31
   PubMed Web of Science ®Google Scholar
• Grover A, Katiyar SP, Singh SK, et al. A leishmaniasis study: structure-based screening and molecular dynamics mechanistic analysis for discovering potent inhibitors of spermidine synthase. Biochim Biophys Acta 2012;1824:1476–83
   PubMed Web of Science ®Google Scholar
• Dhanjal JK, Goyal S, Sharma S, et al. Mechanistic insights into mode of action of potent natural antagonists of BACE-1 for checking Alzheimer's plaque pathology. Biochem Biophys Res Commun 2014;443:1054–9
   PubMed Web of Science ®Google Scholar
• Jorgensen WL. The many roles of computation in drug discovery. Science 2004;303:1813–18
   PubMed Web of Science ®Google Scholar
• Ioakimidis L, Thoukydidis L, Mirza A, et al. Benchmarking the reliability of QikProp. Correlation between experimental and predicted values. QSAR Combin Sci 2008;27:445–56
   Google Scholar
• Kline-Smith SL, Walczak CE. Mitotic spindle assembly and chromosome segregation: refocusing on microtubule dynamics. Mol Cell 2004;15:317–27
   PubMed Web of Science ®Google Scholar
• Nigg EA. Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol 2001;2:21–32
   PubMed Web of Science ®Google Scholar
• Wittmann T, Boleti H, Antony C, et al. Localization of the kinesin-like protein Xklp2 to spindle poles requires a leucine zipper, a microtubule-associated protein, and dynein. J Cell Biol 1998;143:673–85
   PubMed Web of Science ®Google Scholar
• Karsenti E, Vernos I. The mitotic spindle: a self-made machine. Science 2001;294:543–7
   PubMed Web of Science ®Google Scholar
• Eyers PA, Erikson E, Chen LG, Maller JL. A novel mechanism for activation of the protein kinase Aurora A. Curr Biol 2003;3:691–7
   Web of Science ®Google Scholar
• Tsai MY, Wiese C, Cao K, et al. A Ran signalling pathway mediated by the mitotic kinase Aurora A in spindle assembly. Nat Cell Biol 2003;5:242–8
   PubMed Web of Science ®Google Scholar
• Hsueh KW, Fu SL, Chang CB, et al. A novel Aurora-A-mediated phosphorylation of p53 inhibits its interaction with MDM2. Biochim Biophys Acta 2013;1834:508–15
   PubMed Web of Science ®Google Scholar
• Katayama H, Sasai K, Kawai H, et al. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet 2004;36:55–62
   PubMed Web of Science ®Google Scholar
• Sankaran S, Crone DE, Palazzo RE, Parvin JD. Aurora-A kinase regulates breast cancer associated gene 1 inhibition of centrosome-dependent microtubule nucleation. Cancer Res 2007;67:11186–94
   PubMed Web of Science ®Google Scholar
• Zhou H, Kuang J, Zhong L, et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 1998;20:189–93
   PubMed Web of Science ®Google Scholar
• Buschhorn HM, Klein RR, Chambers SM, et al. Aurora-A over-expression in high-grade PIN lesions and prostate cancer. Prostate 2005;64:341–6
   PubMed Web of Science ®Google Scholar
• Gritsko TM, Coppola D, Paciga JE, et al. Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. Clin Cancer Res 2003;9:1420–6
   PubMed Web of Science ®Google Scholar
• Fraizer GC, Diaz MF, Lee IL, et al. Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells. Int J Oncol 2004;25:1631–9
   PubMed Web of Science ®Google Scholar
• Kamada K, Yamada Y, Hirao T, et al. Amplification/overexpression of Aurora-A in human gastric carcinoma: potential role in differentiated type gastric carcinogenesis. Oncol Rep 2004;12:593–9
   PubMed Web of Science ®Google Scholar
• Li Y, Li F, Li-Ling J, et al. STK15 gene overexpression, centrosomal amplification, and chromosomal instability in the absence of STK15 mutations in laryngeal carcinoma. Cancer Invest 2005;23:660–4
   PubMed Web of Science ®Google Scholar
• Li D, Zhu J, Firozi PF, et al. Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin Cancer Res 2003;9:991–7
   PubMed Web of Science ®Google Scholar
• Tanaka T, Kimura M, Matsunaga K, et al. Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res 1999;59:2041–4
   PubMed Web of Science ®Google Scholar
• Wan XB, Long ZJ, Yan M, et al. Inhibition of Aurora-A suppresses epithelial-mesenchymal transition and invasion by downregulating MAPK in nasopharyngeal carcinoma cells. Carcinogenesis 2008;29:1930–7
   PubMed Web of Science ®Google Scholar
• Carter SL, Eklund AC, Kohane IS, et al. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 2006;38:1043–8
   PubMed Web of Science ®Google Scholar
• Ramakrishna M, Williams LH, Boyle SE, et al. Identification of candidate growth promoting genes in ovarian cancer through integrated copy number and expression analysis. PLoS One 2010;5:0009983
   Web of Science ®Google Scholar
• Ma Y, Lin D, Sun W, et al. Expression of targeting protein for xklp2 associated with both malignant transformation of respiratory epithelium and progression of squamous cell lung cancer. Clin Cancer Res 2006;12:1121–7
   PubMed Web of Science ®Google Scholar
• Hauf S, Cole RW, LaTerra S, et al. The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint. J Cell Biol 2003;161:281–94
   PubMed Web of Science ®Google Scholar
• Ditchfield C, Johnson VL, Tighe A, et al. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores. J Cell Biol 2003;161:267–80
   PubMed Web of Science ®Google Scholar
• Harrington EA, Bebbington D, Moore J, et al. VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nat Med 2004;10:262–7
   PubMed Web of Science ®Google Scholar
• Agnese V, Bazan V, Fiorentino FP, et al. The role of Aurora-A inhibitors in cancer therapy. Ann Oncol 2007;18:vi47–52
   PubMed Web of Science ®Google Scholar
• Warner SL, Stephens BJ, Nwokenkwo S, et al. Validation of TPX2 as a potential therapeutic target in pancreatic cancer cells. Clin Cancer Res 2009;15:6519–28
   PubMed Web of Science ®Google Scholar
• Asteriti IA, Rensen WM, Lindon C, et al. The Aurora-A/TPX2 complex: a novel oncogenic holoenzyme? Biochim Biophys Acta 2010;1806:230–9
   PubMed Web of Science ®Google Scholar
• Grover A, Singh R, Shandilya A, et al. Ashwagandha derived withanone targets TPX2-Aurora A complex: computational and experimental evidence to its anticancer activity. PLoS One 2012;7:e30890
   PubMed Web of Science ®Google Scholar
• Goyal M, Dhanjal JK, Goyal S, et al. Development of dual inhibitors against Alzheimer’s disease using fragment-based QSAR and molecular docking. BioMed Res Int 2014;2014:1–12
   Web of Science ®Google Scholar
• Saxena N, Katiyar SP, Liu Y, et al. Molecular interactions of Bcl-2 and Bcl-xL with mortalin: identification and functional characterization. Biosci Rep 2013;33:797–806
   Web of Science ®Google Scholar
• Zhao B, Smallwood A, Yang J, et al. Modulation of kinase-inhibitor interactions by auxiliary protein binding: crystallography studies on Aurora A interactions with VX-680 and with TPX2. Protein Sci 2008;17:1791–7
   PubMed Web of Science ®Google Scholar
• Berman HM, Westbrook J, Feng Z, et al. The protein data bank. Nucl Acids Res 2000;28:235–42
   PubMed Web of Science ®Google Scholar
• Pettersen EF, Goddard TD, Huang CC, et al. UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem 2004;25:1605–12
   PubMed Web of Science ®Google Scholar
• DeLano WL. Pymol: an open-source molecular graphics tool. CCP4 Newslet Prot Crystallogr 2002;40:82–92
   Google Scholar
• DeLano WL. PyMOL. San Carlos (CA): DeLano Scientific; 2002. 700 p
   Google Scholar
• Viewerlite. 5.0 ed. San Diego (CA): Accelrys Inc.; 2002
   Google Scholar
• Protein Preparation Wizard. Epik version 2.0, Impact version 5.5, Prime version 2.1. New York (NY): Schrödinger, LLC; 2009
   Google Scholar
• Schrodinger L. Schrodinger Software Suite. New York (NY): Schrödinger, LLC; 2011
   Google Scholar
• Sastry GM, Adzhigirey M, Day T, et al. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput-Aid Mol Design 2013;27:221–34
   PubMed Web of Science ®Google Scholar
• Irwin JJ, Shoichet BK. ZINC – a free database of commercially available compounds for virtual screening. J Chem Inf Model 2005;45:177–82
   PubMed Web of Science ®Google Scholar
• LigPrep V. 2.3. New York (NY): Schrodinger, LLC; 2009. 703 p
   Google Scholar
• Halgren TA, Murphy RB, Friesner RA, et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 2004;47:1750–9
   PubMed Web of Science ®Google Scholar
• Friesner RA, Banks JL, Murphy RB, et al. Glide: a new approach for rapid, accurate docking and scoring. 1: Method and assessment of docking accuracy. J Med Chem 2004;47:1739–49
   PubMed Web of Science ®Google Scholar
• Friesner RA, Murphy RB, Repasky MP, et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 2006;49:6177–96
   PubMed Web of Science ®Google Scholar
• Shivakumar D, Williams J, Wu Y, et al. Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field. J Chem Theory Comput 2010;6:1509–19
   PubMed Web of Science ®Google Scholar
• Guo Z, Mohanty U, Noehre J, et al. Probing the α-helical structural stability of stapled p53 peptides: molecular dynamics simulations and analysis. Chem Biol Drug Design 2010;75:348–59
   PubMed Web of Science ®Google Scholar
• Bowers KJ, Chow E, Xu H, et al. (eds). Scalable algorithms for molecular dynamics simulations on commodity clusters. SC 2006 Conference. Proceedings of the ACM/IEEE. IEEE, Tampa, FL; 2006
   Google Scholar
• Schrödinger. Desmond molecular dynamics system. Maestro–Desmond interoperability tools. 3.4 ed. New York (NY): D. E. Shaw Research; 2013
   Google Scholar
• Kaminski GA, Friesner RA, Tirado-Rives J, Jorgensen WL. Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides. J Phys Chem B 2001;105:6474–87
   Web of Science ®Google Scholar
• Jorgensen WL, Maxwell DS, Tirado-Rives J. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc 1996;118:11225–36
   Web of Science ®Google Scholar
• Essmann U, Perera L, Berkowitz ML, et al. A smooth particle mesh Ewald method. J Chem Phys 1995;103:8577–93
   Web of Science ®Google Scholar
• Wallace AC, Laskowski RA, Thornton JM. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng 1995;8:127–34
   PubMedGoogle Scholar
• Cheng F, Yu Y, Shen J, et al. Classification of cytochrome P450 inhibitors and noninhibitors using combined classifiers. J Chem Inf Model 2011;51:996–1011
   PubMed Web of Science ®Google Scholar
• Perez de Castro I, Malumbres M. Mitotic stress and chromosomal instability in cancer: the case for TPX2. Genes Canc 2012;3:721–30
   PubMedGoogle Scholar